Henlius Doses First Patient In China For Ophthalmic Bevacizumab

Follows US FDA Approving Henlius’ Investigational New Drug Application

 
• By Dean Rudge
  
Eye
Henlius has also developed bevacizumab for cancer • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products